What's breaking now, across thousands of outlets.
A new study compared power plants’ carbon emissions and found government-owned plants’ emissions were much higher and less responsive to climate policies.
We haven't written up this one. The Conversation has the full story — the link below goes straight to it.
A two-year blockade imposed on Iran by Britain gave way to a coup and leadership change. But seven decades later, circumstances are very different.
Compounding pharmacies will now be able to sell 6 popular peptides, despite the fact they have not been proved safe and effective.
Why are some people hit harder by certain diseases than others? Why do some patients respond better to a treatment, while others see no effect? Biomarkers can help answer these questions.
A big retailer can be both a fierce competitor and a traffic-generating anchor for nearby businesses.
National debt now equals the size of the US economy.
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
